Clinical trial · Interventional
Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients
Validation of Central Venous (Port A Cath®) Blood Draws for Ciprofloxacin Pharmacokinetic Research in Patients Under Treatment for Childhood Cancer
NCT02967341CI-TRIAL-00024824unknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To validate blood draws via a central venous catheter (Port A Cath ®) for pharmacokinetic studies of ciprofloxacin in patients under treatment for childhood cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
| Neutropenia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ciprofloxacin administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Ciprofloxacin administration
- description
- Blood will be drawn, in all participants, via Port A Cath and via a peripheral draw.
- interventionNames
- Other: Ciprofloxacin administration
Primary outcomes (1)
- measure
- Correlation between ciprofloxacin concentration drawn via Port a Cath (PAC) versus capillary/venous punction
- timeFrame
- 1 hour
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Month
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: Children who * are between 1 month and 18 years of age * are under treatment for any type of childhood cancer * use ciprofloxacin for prophylaxis of febrile neutropenia as part of regular treatment * have a PAC for intravenous medication and blood draws. Exclusion Criteria: Children will be excluded from this study if we are unable to * obtain informed consent of both parents and assent of the child (if he/she is over 12 years of age) * aspire blood from the PAC.
References
Publications (0)
Data not yet available
No reference posted for this study.